ArticleJournal of clinical medicine2021

Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study.

Anna Olewicz-Gawlik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.